Author:
Boneberg E-M,Legler D F,Hoefer M M,Öhlschlegel C,Steininger H,Füzesi L,Beer G M,Dupont-Lampert V,Otto F,Senn H-J,Fürstenberger G
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Agarwal B, Saxena R, Morimiya A, Mehrotra S, Badve S (2005) Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 29: 1449–1455
2. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629–641
3. Colomer R, Aparicio J, Montero S, Guzmán C, Larrodera L, Cortés-Funes H (1997) Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. Br J Cancer 76: 1215–1220
4. Dickson PV, Hamner JB, Sims TL, Fraga CH, Ng CY, Rajasekeran S, Hagedorn NL, McCarville MB, Stewart CF, Davidoff AM (2007) Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res 13: 3942–3950
5. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60: 1388–1393
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献